iLite T-Cell Activation Bioassays
A biologically relevant and powerful way to assess CD3 induced T-cell activation
A biologically relevant way to assess CD3 induced T-cell activation
T-Cell Activation Bioassays
Our T-cell Activation Bioassays, based on Svar’s proprietary iLite® technology, are designed to measure the effectiveness of antibodies engaging with CD3 receptors and triggering T-cell activation – a common mechanism of action (MoA) of therapeutic antibodies.
iLite T-Cell Activation Reporter Gene Assays
Our iLite T-cell activation assays utilize a dual-cell system with luciferase readouts, mimicking the natural interaction of the TCR/CD3 complex. This results in a powerful way of measuring the efficacy of antibodies to elicit T cell activation through CD3 interactions.
- Easier workflow than traditional T-cell activation Assays
- "Assay-ready" format for rapid and convenient use
- A secondary reporter gene that acts as an internal control, compensating for differences in cell number and matrix effects
- Reduced assay variability
Our T-Cell Activation Reporter-Gene Assays
FILTER VIEWiLite® CD19 (+) Target
Engineered to express CD19, this cell line is ideal for ADCC and bispecific antibody assays
iLite® CD19 (-) Target
CD19-negative target cell line used as a specificity control in ADCC and T cell engager assays
iLite® CD3 Effector
Optimized for quantifying T cell-mediated cytotoxicity and bispecific antibody function via CD3 engagement
Didn't find what you were looking for?
We offer products customized to your needs. Our custom iLite® reporter-gene assays can be adapted to almost any target. We also offer custom ELISA plates and other products. In addition, you can take advantage of our service offerings and let us do the work for you.
iLite News
iLite Downloads
IL-6 Biology, Inhibitors & COVID-19
Read post
Mechanism-linked Potency Assays Drive Gene Therapy Success
Read post
Addressing the Analytical Gaps in Modern Therapeutic Development
Read post
Developing a Customizable Complement-Dependent Cytotoxicity Assay
Read post
Partnering for Success in a New Era of Advanced Therapeutics
Read post
The Immune Response to AAV Gene Therapy
Read post
How to Design Potency Assays for Gene Therapy Projects
Read post
A Cell-Based ADCC Bioassay Comparison
Read post
Quantification of the Neutralizing Antibody Response to Recombinant AAV Vectors
Read post
Svar Complement Assays: Analyzing How Drug Candidates Affect the Complement System
Read post
Assay Development in AAV Therapies: Engineering iLite® Cell Lines for Specific and Analytical Applic...
Read post
Measuring C5a With a Functional Bioassay
Read post
Establishment of a Novel iLite® Reporter Gene Assay Response to Insulin Products
Read post
Evaluation of iLite® ADCC Effector Cells Using Different CD20 Target Cells
Read post
Development of an FGF21 iLite® Reporter Gene Cell Line
Read postContact our iLite team
Write us a message and a product specialist will get in touch